FDA-Device2018-10-24Class II

Mindray BeneVision Distributed Monitoring System (DMS), Part No. 115-034413-00

Mindray DS USA, Inc. dba Mindray North America
Hazard

The firm has identified performance anomalies with the device caused when more than 64 TD60 telemetry transmitters have been connected to a central station. The anomaly causes some ECG waveforms to appear as a flat line at the centralized viewing station and will manifest if more than 64 TD60 transmitters have been connected to a given central station server. Each central station supports only 32 transmitters at a time. For the issue to manifest, the BeneVision DMS needs to be configured to use flexible device assignment, have more than 64 TD60 transmitters, and the workflow must allow 64 TD60s to move around between multiple central stations in the same care area.

Sold states
Distributed to accounts in CA, CO, FL, MA, NY, PA, PR, TX, and WV.
Affected count
5
Manufactured in
800 Macarthur Blvd, N/A, Mahwah, NJ, United States
Products
Mindray BeneVision Distributed Monitoring System (DMS), Part No. 115-034413-00

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-0170-2019

Don't want to check this manually?

We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Get the Sunday Brief